clipped from cancerbreakthroughusa.com
|
Tuesday, May 19, 2009
parasites
Thursday, May 7, 2009
Experts warn against long-term use of common pain pills
The geriatrics society’s new guidelines say NSAIDs should be considered “rarely” in the population of frail elderly people, and used “with extreme caution” and then only in “highly selected individuals.” For those patients with moderate to severe pain that diminishes the quality of life, opiates may be considered, the guidelines suggest, after both the patient and caregiver are screened for prior substance abuse.
clipped from newoldage.blogs.nytimes.com
|
Researchers Discover Common Antibiotic Can Cure Genetic Diseases
Since releasing the news of the new compound, called NB54, based on the common antibiotic gentamicin, Baasov has been flooded with queries from investigators all over the globe excited to test it, he tells ISRAEL21c. The findings were published online in March in the Journal of Medicinal Chemistry
Gentamicin is from a group of antibiotics known as aminoglycosides, which are used to treat a wide range of bacterial infections. It is commonly used to treat enlarged prostate glands, chest infections, urinary tract infections and infected wounds or burns. Previous studies find gentamicin can work to counteract genetic diseases when mutations cause disruptions of the development processes of proteins
Compound working in cystic fibrosis
The drug enables ribosomes, which carry out protein synthesis, to ignore these genetic disruptions and generate healthy, full-length functional proteins in
clipped from curmudgeonlyskeptical.blogspot.com
The Israeli team headed by Prof. Timor Baasov of the Technion - |
Splenda causes weight gain, impairs digestion, and affects chemotherapy & other drugs
As of 2006, only six human trials have been published on Splenda. Of these six trials, only two of the trials were completed and published before the FDA approved sucralose for human consumption, and the two published trials had a grand total of 36 total human subjects.
36 people sure doesn’t sound like many, but wait, it gets worse: only 23 total were actually given sucralose for testing, and here is the real kicker — The longest trial at this time had lasted only four days, and looked at sucralose in relation to tooth decay, not human tolerance.
Even more shocking, the absorption of Splenda into the human body was studied on a grand total of six men! Based on that one human study, the FDA allowed the findings to be generalized as being representative of the entire human population. Including women, children, the elderly, and those with any chronic illness — none of whom were ever examined.
clipped from www.impactlab.com
published in the Journal of Toxicology and Environmental Health Splenda Has NEVER Been Proven Safe for Human Consumption |